From epidemiology to treatment: Aspirin's prevention of brain and breast-cancer and cardioprotection may associate with its metabolite gentisic acid

Sadeleştirilmiş öğe sayfası
dc.contributor.authorAltinoz, Meric A.
dc.contributor.authorElmaci, Ilhan
dc.contributor.authorCengiz, Salih
dc.contributor.authorEmekli\\-Alturfan, Ebru
dc.contributor.authorOzpinar, Aysel
dc.date.accessioned2025-10-16T15:25:17Z
dc.date.issued2018
dc.identifier.doi10.1016/j.cbi.2018.05.016
dc.identifier.otherWOS:000438310700004
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/8230
dc.publisherELSEVIER IRELAND LTD
dc.sourceCHEMICO-BIOLOGICAL INTERACTIONS
dc.subjectAspirin
dc.subjectGentisic acid
dc.subjectCancer chemoprevention
dc.subjectCancer treatment
dc.subjectSelenium
dc.subjectAnthracycline cardiotoxicity
dc.titleFrom epidemiology to treatment: Aspirin's prevention of brain and breast-cancer and cardioprotection may associate with its metabolite gentisic acid
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS